Advancements in High-Concentration, High-Dose Formulations for SC Administration of Protein Therapeutics

Session details:

• Recognize how non-aqueous biologic formulations are being developed to enable subcutaneous self-administration of high-concentration and high-dose therapies.
• Identify particle-generation and formulation strategies that support non-aqueous biologic formulations while improving the stability and injectability of high-concentration protein therapeutics.
• Be equipped with data to address questions about comparability and safety of non-aqueous formulations.